Status:
RECRUITING
Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem
Lead Sponsor:
Societe dEtude, de Recherche et de Fabrication
Conditions:
Hip Arthropathy
Eligibility:
All Genders
18+ years
Brief Summary
This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. This study will confirm the performance and safety of the SAGI...
Eligibility Criteria
Inclusion
- Patient over 18 years old at the time of surgery,
- Patient implanted with a SAGITTA EVL R revision femoral stem within its indications between 01/01/2010 and 31/12/2015,
- Affiliated to French health insurance system
Exclusion
- Patient who has rejected to the use of his/her personal data,
- Patient unable to understand the surgeon's instructions or to carry out the post-operative follow-up.
Key Trial Info
Start Date :
June 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06096155
Start Date
June 13 2023
End Date
August 31 2024
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Loire Vendée Océan
Challans, Vendée, France, 85300